RedHill Biopharma Ltd. (RDHL) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    RedHill Biopharma Ltd.

    NASDAQ: RDHL · Real-Time Price · USD
    1.80
    0.15 (9.09%)
    At close: Sep 26, 2025, 1:15 PM

    RedHill Biopharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 8.04M 6.53M 61.8M 85.76M
    Cost of Revenue
    		 3.19M 3.46M 33.34M 49.41M
    Gross Profit
    		 4.85M 3.07M 28.46M 36.35M
    Operating Income
    		 -14.61M 12.63M -42.84M -81.14M
    Interest Income
    		 133K 94K 140K 51K
    Pretax Income
    		 -8.27M 23.92M -71.67M -97.74M
    Net Income
    		 -8.27M 23.92M -71.67M -97.74M
    Selling & General & Admin
    		 15.52M 30.98M 64.03M 87.99M
    Research & Development
    		 1.59M 3.53M 7.28M 29.5M
    Other Expenses
    		 2.36M -44.06M n/a n/a
    Operating Expenses
    		 19.46M -9.56M 71.31M 117.49M
    Interest Expense
    		 55K 367K 41.33M 16.57M
    Selling & Marketing Expenses
    		 1M 2.1M 9.06M 11.38M
    Cost & Expenses
    		 22.66M -6.1M 104.64M 166.89M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 2.46M 518.24K 123.86K 93.05K
    Shares Outstanding (Diluted)
    		 2.46M 518.24K 123.86K 93.05K
    EPS (Basic)
    		 n/a 46.00 -600 -1K
    EPS (Diluted)
    		 n/a 46.00 -600 -1K
    EBITDA
    		 -7.59M 26.27M -22.18M -63.03M
    EBIT
    		 -8.21M 24.28M -30.34M -81.18M
    Depreciation & Amortization
    		 619K 1.99M 8.15M 18.15M

    Add to Watchlist